Back to Top
AI Assistant
Home
History
Full Timeline

1980s

1988 to 2004
Automated production period
Chung Mei's research and development closely tracks the trends and health needs of the people in Taiwan. With the economic growth of Taiwan, lifestyles have changed accordingly and thus, Chung Mei's product development targets diseases and preventive medicine related to today's lifestyle habits. At the same time, our beverage and retail departments have been set up to diversify the enterprise's business scope to expand to research and development, manufacturing, distribution, wholesale and retail.

We never compromise our quality.

From our formula design, raw materials selection, effective pharmaceutical ingredients inspection, to manufacturing environment control, and with the help of professional instruments that guarantee efficacy, we strive to let our customers be reassured about our pharmaceutical products.
/
2004
  • Passed validation evaluation by the Department of Health, and rated as third phase cGMP pharmaceutical factory.
  • OTC medicine launched in Hong Kong (Huada Co., Ltd.), and expanded sales to Shenzhen and inland of Mainland China.
2003
  • Passed the validation evaluation by Department of Health, and rated as second phase cGMP pharmaceutical factory.
  • Introduced herbal tea from Germany in Taiwan market.
  • Accepted the R&D request and became the original equipment manufacturer of the Sleepman Tablets from the “Whole Win Pharmaceutical Co., Ltd.”.
  • Accepted the formula R&D request and became the original equipment manufacturer of the Tri-Umbrella Yuluan Solution from “Daiyu Pharmaceutical Co., Ltd.”.
2002
  • Proven efficacy through the “Assisting Traditional Industrial Technology Development Program” ~ “Health Food – Siberian Ginseng Research and Development Project” counseled by the Industrial Development Bureau, Ministry of Economic Affairs: safe quality, and contains the function of elevating immune system.
  • Received counseling from the Department of Commerce on “Chain Store Operation Integration Management” POS system.
2001
  • Passed assessment by the Bureau of Food and Drug Analysis, Department of Health, and was rated as a first phase cGMP pharmaceutical factory.
  • Industrial Development Bureau counseled on the promotion of “Internal Electronic and Professional PDA for Enterprises” project.
2000
  • Mr. Lin Ben-Yuan began to serve as the Director of Taiwan Pharmaceutical Manufacturer Association, and became an industry voice regarding policy establishment and the pharmaceutical market.
  • Established overseas business division in Singapore for the sales of beverages, health foods, and medicines.
  • Received professional counseling from the Department of Commerce on establishing the B to B business system.
1999
  • Participated the “Program of Affiliated Businesses Assisting with Small and Medium-sized Enterprises on Research and Development” of the Ministry of Economic Affairs, and the “Technology Development of Slow-release Preparations” researched and developed by the company passed the research and development application.
  • Signed collaboration contract with the Medical and Pharmaceutical Industry Technology and Development Center on project collaborations of “Evaluation and R&D Counseling on Round Capsule Preparations” and “Formula Design and Manufacturing Process Development of Prolonged Cold Medicine in Capsules Formulation”.
  • Collaborated with the Development Center for Biotechnology on the project of “Mass Production Technology for the Mycelium Fermentation of Hericium Erinaceus”; officially entered the biotechnology field, and initiated the new direction on researching and development for health foods and drugs.
  • Collaborated with Taiwan Kunyang Company, and obtained the domestic market distribution rights for the world patented product – Kewutong prolonged muscle pain patch.
  • Assisted and sponsored the Buddhist Compassion Relief Tzu Chi Foundation on the production of international disaster relief family medicine and health box.
1998
  • Signed collaboration contract with the Medical and Pharmaceutical Industry Technology and Development Center on “Pharmaceutical Technology and Product Development” – on bioequivalence experiment between Atenolol 100mg and Chlorthalidone 25mg compound tablet.
  • Signed collaboration contract with the Medical and Pharmaceutical Industry Technology and Development Center on “Pharmaceutical Technology and Product Development” – advanced technology authorized collaboration for the product development of medicated patch.
1997
  • Obtained the distribution rights of “SMILE A” eye drop in Taiwan from Japan Lion Corporation.
  • Introduced female condoms from the Female Health Company (UK) Plc, and obtained the regional distribution rights of the product.
1996
  • Introduced the automatic packaging machine and liquid agent from Japan.
  • Celebrated the 60th anniversary of the company in Macau.
  • The Sea Lucky Logistics Center was established and began operation.
1995
  • Introduced the number one Australian dietary supplement brand CENOVIS on open-shelf retail stores with reasonable pricing, which lead to the creation of a new era of dietary supplements.
1994
  • Established “Chung Mei’s Health Trend Drugstore Chain” to guide the transformation of subsidiary traditional drugstores into a modern pharmaceutical business to adapt to new trends and changing consumer needs.
1988
  • GMP new plant completed and started to operate.
  • Reviewed and recognized by Industrial regulatory agencies as “GMP implemented pharmaceutical factory”.
Back to History